[1] 黄凯, 蒋世云, 陈柳军. 5-脂氧合酶及其抑制剂[J]. 中国生物化学与分子生物学报, 2014, 30(12):1190-1196.
[2] Chen Y, Hu Y, Zhang H, et al.Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia[J]. Nat Genet, 2009, 41(7):783-792.
[3] Chen Y, Peng C, Sullivan C, et al.Critical molecular pathways in cancer stem cells of chronic myeloid leukemia[J]. Leukemia, 2010, 24(9):1545-1554.
[4] Roos J, Oancea C, et al.5-Lipoxygenase is a candidate target for therapeutic management of stem cell-likecells in acute myeloid leukemia[J]. Cancer Res, 2014, 74(18):5244-5255.
[5] Lone BA, Karna SKL, et al.CRISPR/Cas9 system:A bacterial tailor for genomic engineering[J]. Genet Res Int, 2018:3797214.
[6] Naert T, Vleminckx K.Genotyping of CRISPR/Cas9 genome edited Xenopus tropicalis[J]. Methods Mol Biol, 2018, 1865:67-82.
[7] 贾启鹏, 申培磊, 张欢, 等. CRISPR/Cas9系统介导敲除CSN2基因奶山羊胎儿成纤维突变细胞的制备[J]. 生物技术通报, 2017, 33(9):131-138.
[8] 马晓丽, 景巧丽, 裴雁曦. 基于CRISPR/Cas9技术的大白菜内源硫化氢生成酶LCD基因突变体构建[J]. 中国细胞生物学学报, 2018, 40(11):1799-1805.
[9] 姚恒, 杨大海, 白戈, 等. 利用CRISPR/Cas9技术定点敲除烟草多酚氧化酶基因NtPPO1[J]. 生物技术通报, 2018, 34(11):97-102.
[10] 唐石树, 胡建安. 5-脂氧合酶在人体组织中的表达及其与疾病的关系[J]. 中南大学学报:医学版, 2015, 40(4):438-445.
[11] Mashima R, Okuyama T.The role of lipoxygenases in pathophysiology;new insights and future perspectives[J]. Redox Biol, 2015, 6:297-310.
[12] Che XH, Chen CL, Ye XL, et al.Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro[J]. Oncol Rep, 2016, 35(3):1680-1688.
[13] Sarveswaran S, Varma N, Morisetty S, et al.Inhibition of 5-lipoxygenase downregulates stemness and kills prostate cancer stem cells by triggering apoptosis via activation of c-Jun N-terminal kinase[J]. Oncotarget, 2016, 17.
[14] Bishayee K, Khuda-Bukhsh AR.5-lipoxygenase antagonist ther-apy:a new approach towards targeted cancer chemotherapy[J]. Acta Biochim Biophys Sin, 2013, 45(9):709-719.
[15] Anderson KM, Seed T, et al.Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induce limited differentia-tion and apoptosis[J]. Leuk Res, 1995, 19(11):789-801.
[16] Rådmark OP.The molecular biology and regulation of 5-lipoxyge-nase[J]. Am J Respir Crit Care Med, 2000, 161(2):S11-S15.
[17] Lo MC, Peterson LF, Yan M, et al.Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21)AML[J]. Blood, 2012, 120(7):1473-1484.
[18] Woessner DW, Lim CS.Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation[J]. Mol Pharm, 2013, 10(1):270-277.
[19] Hu Y, Chen Y, Douglas L, et al.beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia[J]. Leukemia, 2009, 23(1):109-116.
[20] Wang Y, Krivtsov AV, Sinha AU, et al.The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML[J]. Science, 2010, 327(5973):1650-1653.
[21] 雒钰杰, 徐敏, 高雯琬, 等. 敲低花生四烯酸5脂加氧酶(Alox5)基因促进K562/ADM细胞凋亡[J]. 细胞与分子免疫学杂志, 2017, 33(10):1398-1403.
[22] 王大勇, 马宁, 惠洋, 等. CRISPR/Cas9基因组编辑技术在癌症研究中的应用[J]. 遗传, 2016, 38(1):1-8.
[23] Ran FA, Hsu PD, et al.Genome engineering using the CRISPR-Cas9 system[J]. Nat Protoc, 2013, 8(11):2281-2308. |